Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: Problems and prospects

47Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To better support the design of peptide-based vaccines, refinement of methods to predict B-cell epitopes necessitates meaningful benchmarking against empirical data on the cross-reactivity of polyclonal antipeptide antibodies with proteins, such that the positive data reflect functionally relevant cross-reactivity (which is consistent with antibody-mediated change in protein function) and the negative data reflect genuine absence of cross-reactivity (rather than apparent absence of cross-reactivity due to artifactual masking of B-cell epitopes in immunoassays). These data are heterogeneous in view of multiple factors that complicate B-cell epitope prediction, notably physicochemical factors that define key structural differences between immunizing peptides and their cognate proteins (e.g., unmatched electrical charges along the peptide-protein sequence alignments). If the data are partitioned with respect to these factors, iterative parallel benchmarking against the resulting subsets of data provides a basis for systematically identifying and addressing the limitations of methods for B-cell epitope prediction as applied to vaccine design. © 2010 Salvador Eugenio C. Caoili.

Cite

CITATION STYLE

APA

Caoili, S. E. C. (2010). Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: Problems and prospects. Journal of Biomedicine and Biotechnology. https://doi.org/10.1155/2010/910524

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free